The effect of uteroglobin on cPLA2, COX-2 expression and ERK activation in NSCLC cells

Tuberculosis and Respiratory Diseases

Volumn 56, Issue 6, 2004, Pages 638-645

  Kim, Woo Jin ^a   Yoon, Jung Min ^a   Lee, Kyoung Hee ^a   Han, Seon Jin ^a   Shin, Won Hyuk ^a   Yim, Jae Joon ^a   Yoo, Chul Gyu ^a   Lee, Choon Taek ^a   Han, Sung Koo ^a   Shim, Young Soo ^a   Kim, Young Whan ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

COX 2; CPLA2; ERK; Lung cancer; Uteroglobin

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHOLIPASE A2; UTEROGLOBIN;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG NON SMALL CELL CANCER; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 4444276797     PISSN: 03780066     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2004.56.6.638     Document Type: Article

References (26)

1. Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S et al. Uteroglobin: a novel cytokine? Cell Mol Life Sci 1999;55:771-87
2. Linnoila RI, Szabo E, Demayo F, Witschi H, Sabourin C, Malkinson A. The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression. Ann N Y Acad Sci. 2000;923:249-67.
3. Szabo E, Goheer A, Witschi H, Linnoila RI. Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ 1998;9:475-485
4. Zhang Z, Kundu GC, Panda D, Mandal AK, Mantile-Selvaggi G, Peri A et al. Loss of transformed phenotyped in cancer cells by overexpression of the uteroglobin gene. Proc Natl Acad Sci USA 1999;96:3963-8
5. Kundu GC, Mandal AK, Zhang Z, Mantile-Selvaggi G, Mukherjee AB. Uteroglobin suppresses extracellular matrix invasion by normal and cancer cels that express the high affinity UG-binding proteins. J Biol Chem 1998;273:22819-24
6. Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem 1997;272:14501-4
7. Putten VV, Refaat Z, Dessez C, Blaine S, Wick M, Butterfield L et al. Induction of cytosolic phospholipase A2 by oncogenic Ras ia mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem 2001;276:1226-32
8. Blaine SA, Wick M, Dessez C, Nemenoff RA. Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J Biol Chem 2001;276:42737-43
9. Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y et al. Increased COX-2 expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 2000;30:73-81
10. Hasturk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer 2002;94:1023-31
11. Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T et al. Cyclooxygenase-2 inhibitor induced apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 2000;6:2006-11
12. Hung W, Chang H, Pan M, Lee T, Chuang L. Induction of p27 as a mechanism underlying NS398 induced growth inhibition in human lung cancer cells. Mol Pharmacol 2000;58:1398-1406
13. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat Med 2002; 3:289-293
14. JC Lee, KH Park, SJ Han, CG Yoo, CT Lee, SK Han et al. The inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines. Cancer Gene Therapy 2003;10:287-293
15. Peri A, Bonaccorsi L, Muratori M, Luconi M, Balci E, Granchi S et al. Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. Int J Cancer 2000; 88:525-534
16. Jiang YJ, Hatch GM, Mymin D, Dembinski T, Kroeger EA, Choy PC. Modulation of cytosoloic phospholipase A2 by PPAR activators in human preadipocytes. J Lipid Res 2001;42:716-724
17. Levy R, Dana R, Hazan I, Levy I, Weber G, Smoilakov R et al. Elevated cytosolic phosphlipase A2 expression and activity in human neutrophils during sepsis. Blood 2000; 95:660-5
18. Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M et al. Frequent co-localization of Cox-2 and laminin-5 v2 chain at the invasive front of early-stage lung adonocarcinomas. Am J Pathol 2002;160:1129-41
19. Tamura M, Sebastian S, Yang S, Gurates B, Ferrer K, Sasano H et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial cells. J Biol Chem 2002;277:26208-16
20. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells. Cancer Res 2001;61: 2720-6
21. Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M et al. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology 2002;35:1117-1124
22. Galve-Roperh I, Sanchez C, Cortes ML, Pulgar TG, Izquierdo M, Guzman M. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000;6:313-319
23. Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997;94:448-52
24. Elder DJ, Halton DE, Playle LC, Paraskeva C. The MEK/ERK pathway mediated COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Int J Cancer 2002;99:323-7
25. Pan MR, Hung WC. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediaated transcription. J Biol Chem 2002; 277:32775-80
26. Park MJ, Park IC, Lee HC, Woo SH, Lee JY, Hong YJ et al. Protein kinase C-alpha activation by phorbol ester induces secretion of gelatinase B/MMP-9 through ERK 1/2 pathway in capillary endothelial cells. Int J Oncol. 2003;22:137-43